Research & Literature

Natural history and outcomes in localised immunoglobulin light-chain amyloidosis: a long-term observational study.

Mahmood S, Bridoux F, Venner CP, et al.

The Lancet. Haematology 2015; (2(6)):e241-50.

Pathophysiology of pruritus in primary localized cutaneous amyloidosis.

Tey HL, Cao T, Nattkemper LA, et al.

The British journal of dermatology 2016; (174(6)):1345-50 doi:10.1111/bjd.14391.

Free light chain testing for the diagnosis, monitoring and prognostication of AL amyloidosis.

Mollee P, Merlini G

Clinical chemistry and laboratory medicine 2016; (54(6)):921-7.

Treatment of primary cutaneous amyloidosis with laser: a review of the literature.

Al Yahya RS

Lasers in medical science 2016; (31(5)):1027-35 doi:10.1007/s10103-016-1917-8.

Oral isotretinoin: A new treatment alternative for generalized lichen amyloidosis.

Atacan D, Ergin C, Çelik G, et al.

The Australasian journal of dermatology 2016; (57(3)):246-7 doi:10.1111/ajd.12316.

Primary localized cutaneous amyloidosis with lichen and poikiloderma-like lesions and an excellent response to systemic acitretin.

Ma H, Su X, Zhu G, et al.

Anais brasileiros de dermatologia 2016; (91(5)):661-663 doi:10.1590/abd1806-4841.20164316.

Therapeutic efficacy and safety of oral tranexamic acid and that of tranexamic acid local infiltration with microinjections in patients with melasma: a comparative study.

Sharma R, Mahajan VK, Mehta KS, et al.

Clinical and experimental dermatology 2017; (42(7)):728-734 doi:10.1111/ced.13164.

[Identification of pathogenic mutations in two Chinese families affected with primary localized cutaneous amyloidosis].

Mao B, Yao X, Wang Z, Zhao X

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2018; (35(1)):9-13 doi:10.3760/cma.j.issn.1003-9406.2018.01.002.

Comparative study of fractional CO2 laser and fractional CO2 laser-assisted drug delivery of topical steroid and topical vitamin C in macular amyloidosis.

Sobhi RM, Sharaoui I, El Nabarawy EA, et al.

Lasers in medical science 2018; (33(4)):909-916 doi:10.1007/s10103-018-2457-1.

Metastatic pheochromocytoma in MEN 2A: A rare association.

Pal R, Rastogi A, Kumar S, Bhansali A

BMJ case reports 2018; (2018()) doi:10.1136/bcr-2017-222758.

Subcutaneous scalp nodule as the presenting symptom of systemic light-chain amyloidosis.

Tadros J, Goodman S, Tkaczyk ER

Dermatology practical & conceptual 2018; (8(3)):184-187 doi:10.5826/dpc.0803a07.

Image Gallery: Dermoscopy of lichen amyloidosis.

Moscarella E, Ronchi A, Agozzino M, et al.

The British journal of dermatology 2018; (179(6)):e231 doi:10.1111/bjd.17109.

A novel mass spectrometry method to identify the serum monoclonal light chain component in systemic light chain amyloidosis.

Sharpley FA, Manwani R, Mahmood S, et al.

Blood cancer journal 2019; (9(2)):16 doi:10.1038/s41408-019-0180-1.

Clinical and genetic features of Chinese patients with lichen and macular primary localized cutaneous amyloidosis.

Lu P, Wu FF, Rong ZL, et al.

Clinical and experimental dermatology 2019; (44(4)):e110-e117 doi:10.1111/ced.13925.

Primary Localized Cutaneous Nodular Amyloidosis on a Toe: Clinical Presentation, Histopathology, and Dermoscopy Findings.

Ferreira ILO, Fernandes EL, Lapins J, et al.

Dermatology practical & conceptual 2019; (9(3)):235-236 doi:10.5826/dpc.0903a18.

The therapeutic effects of 1540-nm nonablative fractional erbium laser on macular amyloidosis: a randomized clinical trial.

Nahidi Y, Delghandi SR, Kiafar B, Saki A

The Journal of dermatological treatment 2021; (32(3)):340-344 doi:10.1080/09546634.2019.1655136.

Clinical Efficacy of Topical Tranexamic Acid With Microneedling in Melasma.

Kaur A, Bhalla M, Pal Thami G, Sandhu J

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2020; (46(11)):e96-e101 doi:10.1097/DSS.0000000000002520.

Primary cutaneous nodular amyloidosis associated with the injection of autologous fat.

Mena L, Carrasco C, Folch H, et al.

Clinical and experimental dermatology 2021; (46(3)):552-554 doi:10.1111/ced.14429.

Clinical resolution of generalized lichen amyloidosis with dupilumab: a new alternative therapy.

Humeda Y, Beasley J, Calder K

Dermatology online journal 2020; (26(12)).

Primary cutaneous amyloidosis: A clinicopathological, histochemical, and immunohistochemical study.

Sinha A, Manjunath GV, Basavaraj V

Indian journal of pathology & microbiology 2021; (64(2)):323-328 doi:10.4103/IJPM.IJPM_32_20.

FotoFinder Dermoscopy Analysis and Histopathological Correlation in Primary Localized Cutaneous Amyloidosis.

Madarkar MS, Koti VR

Dermatology practical & conceptual 2021; (11(3)):e2021057 doi:10.5826/dpc.1103a57.

Secondary Localized Cutaneous Amyloidosis is not Rare in Bowen's Disease and Bowenoid Papulosis.

Baykal C, Hurdogan O, Kobaner GB, et al.

Turk patoloji dergisi 2022; (38(1)):54-59 doi:10.5146/tjpath.2021.01530.

A Peculiar Case of Large and "Unresectable" Primary Localized Cutaneous Nodular Amyloidosis of the Ankle.

Stanizzi A, Torresetti M, Barbisan F, et al.

Case reports in dermatology 2021; (13(3)):502-505 doi:10.1159/000519030.

Tofacitinib for the treatment of primary cutaneous amyloidosis: A case report.

Chen J, Yang B

Dermatologic therapy 2022; (35(4)):e15312 doi:10.1111/dth.15312.

Diagnosing of primary cutaneous amyloidosis using dermoscopy and reflectance confocal microscopy.

Lei W, Ai-E X

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) 2022; (28(3)):433-438 doi:10.1111/srt.13143.

Refractory cutaneous lichen amyloidosis coexisting with atopic dermatitis responds to the Janus Kinase inhibitor baricitinib.

Xia D, Xiao Y, Li M, Li W

Dermatologic therapy 2022; (35(9)):e15724 doi:10.1111/dth.15724.

Dermoscopy aids in differentiating primary cutaneous amyloidosis and post-inflammatory hyperpigmentation: A clinico-dermoscopic-histopathaological study.

El-Samanoudy SI, Gawdat HI, Fouda KM, Abdelkader HA

Journal of cosmetic dermatology 2022; (21(11)):6434-6440 doi:10.1111/jocd.15332.

Topical halometasone cream combined with fire needle pre-treatment for treatment of primary cutaneous amyloidosis: Two case reports.

Su YQ, Liu ZY, Wei G, Zhang CM

World journal of clinical cases 2022; (10(20)):7147-7152 doi:10.12998/wjcc.v10.i20.7147.

Localized light chain amyloidosis: A self-limited plasmacytic B-cell lymphoproliferative disorder.

Martínez JC, Lichtman EI

Frontiers in oncology 2022; (12()):1002253 doi:10.3389/fonc.2022.1002253.

Localized Cutaneous Nodular Amyloidosis: A Specific Cutaneous Manifestation of Sjögren's Syndrome.

Llamas-Molina JM, Velasco-Amador JP, De la Torre-Gomar FJ, et al.

International journal of molecular sciences 2023; (24(8)) doi:10.3390/ijms24087378.

A Case Report of Generalized Non-pruritic Lichen Amyloidosis.

Rousseau MA, Valek SA, Rashid RM

Cureus 2023; (15(6)):e39817 doi:10.7759/cureus.39817.

Nodular Cutaneous Amyloidosis on the Nose Confirmed Using Electron Microscopy: A Case Report.

Choi GW, Kim DH

Annals of dermatology 2023; (35(Suppl 2)):S376-S377 doi:10.5021/ad.22.075.

The effect of topical tranexamic acid with micro-needling and micro-needling alone in treatment of macular amyloidosis.

Gheisari M, Ghalamkarpour F, Moslemi Haghighi S, et al.

Journal of cosmetic dermatology 2024; (23(12)):3968-3973 doi:10.1111/jocd.16517.

[Endogenous skin overloads].

Ortonne N

Annales de pathologie 2024; (44(6)):476-485 doi:10.1016/j.annpat.2024.09.006.

Detailed primary localised cutaneous nodular amyloidosis clinical and pathological workup.

Ayub M, Kaminoff L, Maity A, Ali Z

BMJ case reports 2024; (17(11)) doi:10.1136/bcr-2024-262126.

Endocrine Perspective of Cutaneous Lichen Amyloidosis: RET-C634 Pathogenic Variant in Multiple Endocrine Neoplasia Type 2.

Florescu AF, Sima OC, Nistor C, et al.

Clinics and practice 2024; (14(6)):2284-2299 doi:10.3390/clinpract14060179.

Dupilumab for treatment of primary cutaneous amyloidosis in adults: two case reports and literature review.

Guo F, Zhong H, Wu Y, et al.

Frontiers in medicine 2025; (12()):1485079 doi:10.3389/fmed.2025.1485079.

34βE12 is the Most Reliable Marker for Keratin-Derived Cutaneous Amyloid: A Comparative Study.

Daruish M, Al-Sharbatee G, D'Arrigo C, Taibjee S

The American Journal of dermatopathology 2025; (47(6)):439-441 doi:10.1097/DAD.0000000000002942.

A suspicious nodule in a toe web space.

Gilbert G, Wiggins J, Biswas A, Gupta G

Clinical and experimental dermatology 2025; (50(8)):1704-1706 doi:10.1093/ced/llaf113.

Histopathological Insights into Primary Localized Cutaneous Amyloidosis: A Case Series.

Einstien D, G S, Vishali V M S, et al.

Cureus 2025; (17(2)):e79603 doi:10.7759/cureus.79603.

Immunoglobulin heavy/light chain assay in the diagnosis, monitoring and follow-up of renal AL amyloidosis patients at different disease stages.

Wang Y, Liu F, Liu Y, et al.

Annals of hematology 2025; (104(4)):2287-2295 doi:10.1007/s00277-025-06345-7.

Treatment of primary cutaneous amyloidosis with tofacitinib: preliminary observations from a single-arm clinical trial.

Zou P, Du Y, Cao Y, et al.

Clinical and experimental dermatology 2025; (51(1)):86-91 doi:10.1093/ced/llaf364.

More Than Just a Plaque: A Diagnostic Challenge in a Case of Suspected Cutaneous Localized Nodular Amyloidosis.

Shah S, Shrestha J

Clinical case reports 2025; (13(11)):e71514 doi:10.1002/ccr3.71514.